Skip to content
10-Q

Quarterly Report

Aravive, Inc.

0001437749-23-013588

← back to feed
Filed
May 10, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 5, 2023 59.84M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$17.75M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$12.89M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $35.92M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $53.69M
Stockholders Equity Q1 2023 · Mar 31, 2023 −$38.61M
Stockholders Equity Q1 2023 · Dec 31, 2022 $10.66M
Stockholders Equity Q1 2023 · Mar 31, 2022 $39.2M
Stockholders Equity Q1 2023 · Dec 31, 2021 $42.22M
Current Liabilities Q1 2023 · Mar 31, 2023 $20.19M
Current Liabilities Q1 2023 · Dec 31, 2022 $22.11M
Total Liabilities Q1 2023 · Mar 31, 2023 $81.66M
Total Liabilities Q1 2023 · Dec 31, 2022 $51.5M
Current Assets Q1 2023 · Mar 31, 2023 $39.06M
Current Assets Q1 2023 · Dec 31, 2022 $57.97M
Total Assets Q1 2023 · Mar 31, 2023 $43.04M
Total Assets Q1 2023 · Dec 31, 2022 $62.15M
Eps Basic Q1 2023 · Mar 31, 2023 −$0.66
Eps Basic Q1 2023 · Mar 31, 2022 −$0.62
Sga Expense Q1 2023 · Mar 31, 2023 $3.49M
Sga Expense Q1 2023 · Mar 31, 2022 $3.09M
Net Income Q1 2023 · Mar 31, 2023 −$49.96M
Net Income Q1 2023 · Mar 31, 2022 −$13.06M
Operating Income Q1 2023 · Mar 31, 2023 −$17.91M
Operating Income Q1 2023 · Mar 31, 2022 −$15M
Revenue Q1 2023 · Mar 31, 2023 $1.49M
Revenue Q1 2023 · Mar 31, 2022 $1.09M